Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion

Hornigold, N; Dunn, KR; Craven, RA; Zougman, A; Trainor, S; Shreeve, R; Brown, J; Sewell, H; Shires, M; Knowles, M; Fukuwatari, T; Maher, ER; Burns, J; Bhattarai, S; Menon, M; Brazma, A; Scelo, G; Feulner, L; Riazalhosseini, Y; Lathrop, M; Harris, A; Selby, PJ; Banks, RE; Vasudev, NS

Journal article

Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion

Abstract:: Background

Indoleamine 2,3-dioxygenase (IDO), the first step in the kynurenine pathway (KP), is upregulated in some cancers and represents an attractive therapeutic target given its role in tumour immune evasion. However, the recent failure of an IDO inhibitor in a late phase trial raises questions about this strategy.

Methods

Matched renal cell carcinoma (RCC) and normal kidney tissues were subject to proteomic profiling. Tissue immunohistochemistry and gene expression data were used to validate findings. Phenotypic effects of loss/gain of expression were examined in vitro.

Results

Quinolate phosphoribosyltransferase (QPRT), the final and rate-limiting enzyme in the KP, was identified as being downregulated in RCC. Loss of QPRT expression led to increased potential for anchorage-independent growth. Gene expression, mass spectrometry (clear cell and chromophobe RCC) and tissue immunohistochemistry (clear cell, papillary and chromophobe), confirmed loss or decreased expression of QPRT and showed downregulation of other KP enzymes, including kynurenine 3-monoxygenase (KMO) and 3-hydroxyanthranilate-3,4-dioxygenase (HAAO), with a concomitant maintenance or upregulation of nicotinamide phosphoribosyltransferase (NAMPT), the key enzyme in the NAD+ salvage pathway.

Conclusions

Widespread dysregulation of the KP is common in RCC and is likely to contribute to tumour immune evasion, carrying implications for effective therapeutic targeting of this critical pathway.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Hornigold, N., Dunn, K. R., Craven, R. A., Zougman, A., Trainor, S., Shreeve, R., Brown, J., Sewell, H., Shires, M., Knowles, M., Fukuwatari, T., Maher, E. R., Burns, J., Bhattarai, S., Menon, M., Brazma, A., Scelo, G., Feulner, L., Riazalhosseini, Y., … Vasudev, N. S. (2020). Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion. British Journal of Cancer, 123(1), 137–147.

MLA Style

Hornigold, N., et al. “Dysregulation at Multiple Points of the Kynurenine Pathway Is a Ubiquitous Feature of Renal Cancer: Implications for Tumour Immune Evasion.” British Journal of Cancer, vol. 123, no. 1, Springer Nature, 2020, pp. 137–47.

Chicago Style

Hornigold, N, KR Dunn, RA Craven, A Zougman, S Trainor, R Shreeve, J Brown, et al. 2020. “Dysregulation at Multiple Points of the Kynurenine Pathway Is a Ubiquitous Feature of Renal Cancer: Implications for Tumour Immune Evasion.” British Journal of Cancer 123 (1): 137–47.
Share
Print